S
PPH icon

SignatureFD’s VanEck Pharmaceutical ETF PPH Stock Holding History

SignatureFD’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-65
Closed -$5.92K – 3386
2025
Q1 		$5.92K Hold
65
– – ﹤0.01% 2538
2024
Q4 		$5.61K Hold
65
– – ﹤0.01% 2566
2024
Q3 		$6.18K Hold
65
– – ﹤0.01% 2508
2024
Q2 		$5.95K Buy
+65
New +$5.8K ﹤0.01% 2457
2022
Q2 		– Sell
-355
Closed -$28K – 3294
2022
Q1 		$28K Hold
355
– – ﹤0.01% 1674
2021
Q4 		$27K Hold
355
– – ﹤0.01% 1652
2021
Q3 		$26K Hold
355
– – ﹤0.01% 1637
2021
Q2 		$26K Hold
355
– – ﹤0.01% 1617
2021
Q1 		$25K Hold
355
– – ﹤0.01% 1482
2020
Q4 		$24K Buy
+355
New +$22.7K ﹤0.01% 1378

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

SignatureFD's PPH Position: Q2 2025 in Review

SignatureFD sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2025, closing a stake of 65 shares — an estimated $5.92K sold.

SignatureFD first reported a position in PPH in Q4 2020 and held it in 10 quarters. The position peaked at $28K in Q1 2022. 129 funds tracked by Wall St. Rank hold PPH as of Q2 2025.

  • SignatureFD reported no remaining VanEck Pharmaceutical ETF position as of Q2 2025 after selling out during the quarter.
  • SignatureFD sold 65 VanEck Pharmaceutical ETF shares in Q2 2025, an estimated $5.92K.
  • SignatureFD first reported a position in VanEck Pharmaceutical ETF in Q4 2020 and held it in 10 quarters.
  • SignatureFD's VanEck Pharmaceutical ETF position peaked at $28K in Q1 2022.
  • 129 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2025.

Based on SignatureFD's 13F filing for Q2 2025, filed 16 Jul 2025.